ICU Medical Inc (ICUI) - Total Assets
Based on the latest financial reports, ICU Medical Inc (ICUI) holds total assets worth $4.05 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ICU Medical Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
ICU Medical Inc - Total Assets Trend (1991–2025)
This chart illustrates how ICU Medical Inc's total assets have evolved over time, based on quarterly financial data. Check asset resilience ratio of ICU Medical Inc to evaluate the company's liquid asset resilience ratio.
ICU Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
ICU Medical Inc's total assets of $4.05 Billion consist of 29.1% current assets and 70.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 7.6% |
| Accounts Receivable | $180.51 Million | 4.5% |
| Inventory | $615.86 Million | 15.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $633.56 Million | 15.6% |
| Goodwill | $1.50 Billion | 37.0% |
Asset Composition Trend (1991–2025)
This chart illustrates how ICU Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ICUI market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ICU Medical Inc's current assets represent 29.1% of total assets in 2025, a decrease from 83.7% in 1991.
- Cash Position: Cash and equivalents constituted 7.6% of total assets in 2025, down from 55.8% in 1991.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 52.0% of total assets, an increase from 0.0% in 1991.
- Asset Diversification: The largest asset category is goodwill at 37.0% of total assets.
ICU Medical Inc Competitors by Total Assets
Key competitors of ICU Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151
|
China | CN¥4.77 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
|
China | CN¥2.06 Billion |
|
Caina Technology Co. Ltd.
SHE:301122
|
China | CN¥2.24 Billion |
|
IVF Hartmann Holding AG
SW:VBSN
|
Switzerland | CHF180.92 Million |
|
Dentium
KO:145720
|
Korea | ₩932.79 Billion |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$1.42 Billion |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
ICU Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.36 | 2.59 | 5.12 |
| Quick Ratio | 1.13 | 1.54 | 3.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $678.58 Million | $885.80 Million | $741.77 Million |
ICU Medical Inc - Advanced Valuation Insights
This section examines the relationship between ICU Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.50 |
| Latest Market Cap to Assets Ratio | 0.77 |
| Asset Growth Rate (YoY) | -3.6% |
| Total Assets | $4.05 Billion |
| Market Capitalization | $3.11 Billion USD |
Valuation Analysis
Below Book Valuation: The market values ICU Medical Inc's assets below their book value (0.77x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: ICU Medical Inc's assets decreased by 3.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for ICU Medical Inc (1991–2025)
The table below shows the annual total assets of ICU Medical Inc from 1991 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $4.05 Billion | -3.65% |
| 2024-12-31 | $4.20 Billion | -3.99% |
| 2023-12-31 | $4.38 Billion | -3.04% |
| 2022-12-31 | $4.52 Billion | +140.10% |
| 2021-12-31 | $1.88 Billion | +6.64% |
| 2020-12-31 | $1.76 Billion | +4.21% |
| 2019-12-31 | $1.69 Billion | +6.75% |
| 2018-12-31 | $1.59 Billion | +5.91% |
| 2017-12-31 | $1.50 Billion | +112.43% |
| 2016-12-31 | $704.69 Million | +12.42% |
| 2015-12-31 | $626.83 Million | +15.84% |
| 2014-12-31 | $541.10 Million | +8.30% |
| 2013-12-31 | $499.64 Million | +16.60% |
| 2012-12-31 | $428.51 Million | +17.82% |
| 2011-12-31 | $363.69 Million | +16.48% |
| 2010-12-31 | $312.23 Million | +0.99% |
| 2009-12-31 | $309.15 Million | +9.07% |
| 2008-12-31 | $283.43 Million | +16.83% |
| 2007-12-31 | $242.59 Million | -0.68% |
| 2006-12-31 | $244.25 Million | +19.42% |
| 2005-12-31 | $204.54 Million | +24.14% |
| 2004-12-31 | $164.77 Million | +0.29% |
| 2003-12-31 | $164.29 Million | +4.62% |
| 2002-12-31 | $157.03 Million | +33.82% |
| 2001-12-31 | $117.34 Million | +26.36% |
| 2000-12-31 | $92.86 Million | +23.16% |
| 1999-12-31 | $75.40 Million | +20.83% |
| 1998-12-31 | $62.40 Million | +21.88% |
| 1997-12-31 | $51.20 Million | +3.23% |
| 1996-12-31 | $49.60 Million | +3.55% |
| 1995-12-31 | $47.90 Million | +82.13% |
| 1994-12-31 | $26.30 Million | +11.44% |
| 1993-12-31 | $23.60 Million | +24.21% |
| 1992-12-31 | $19.00 Million | +341.86% |
| 1991-12-31 | $4.30 Million | -- |
About ICU Medical Inc
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and admin… Read more